Andrea. Vecchione, et.al., Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development., Cancer cell, 2007, 11

http://rdf.ncbi.nlm.nih.gov/pubmed/17349584

Andrea. Vecchione, et.al., Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development., Cancer cell, 2007, 11

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Lzts1<tm1Cro>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3706174

class

http://purl.org/net/cito/citesAsAuthority

• Lzts1<tm1Cro>
  http://metadb.riken.jp/db/mgi_rdf/MGI:3706174

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased lymphoma incidence_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0012431I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased gastric adenocarcinoma incidence_Lzts1<tm1Cro>/Lzts1<+>
  http://metadb.riken.jp/0008010I129C57BL6JLzts1tm1CroLzts1Lzts1Lzts1tm1Cro
• increased lung adenoma incidence_Lzts1<tm1Cro>/Lzts1<+>
  http://metadb.riken.jp/0002048I129C57BL6JLzts1tm1CroLzts1Lzts1Lzts1tm1Cro
• increased stomach tumor incidence_Lzts1<tm1Cro>/Lzts1<+>
  http://metadb.riken.jp/0010301I129C57BL6JLzts1tm1CroLzts1Lzts1Lzts1tm1Cro
• increased lung adenocarcinoma incidence_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0002027I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased fibroblast apoptosis_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0013501I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased mammary gland tumor incidence_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0010299I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• abnormal cell cycle_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0003077I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased gastric adenocarcinoma incidence_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0008010I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased tumor incidence_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0002020I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased mammary gland tumor incidence_Lzts1<tm1Cro>/Lzts1<+>
  http://metadb.riken.jp/0010299I129C57BL6JLzts1tm1CroLzts1Lzts1Lzts1tm1Cro
• increased carcinoma incidence_Lzts1<tm1Cro>/Lzts1<+>
  http://metadb.riken.jp/0002038I129C57BL6JLzts1tm1CroLzts1Lzts1Lzts1tm1Cro
• increased lymphoma incidence_Lzts1<tm1Cro>/Lzts1<+>
  http://metadb.riken.jp/0012431I129C57BL6JLzts1tm1CroLzts1Lzts1Lzts1tm1Cro
• increased hepatocellular carcinoma incidence_Lzts1<tm1Cro>/Lzts1<+>
  http://metadb.riken.jp/0003331I129C57BL6JLzts1tm1CroLzts1Lzts1Lzts1tm1Cro
• abnormal cell physiology_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0005621I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased sarcoma incidence_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0002032I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• decreased fibroblast proliferation_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0011704I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased tumor incidence_Lzts1<tm1Cro>/Lzts1<+>
  http://metadb.riken.jp/0002020I129C57BL6JLzts1tm1CroLzts1Lzts1Lzts1tm1Cro
• increased hepatocellular carcinoma incidence_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0003331I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased carcinoma incidence_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0002038I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro
• increased stomach tumor incidence_Lzts1<tm1Cro>/Lzts1<tm1Cro>
  http://metadb.riken.jp/0010301I129C57BL6JLzts1tm1CroLzts1tm1CroLzts1tm1Cro

トランスクリプトームデータ

http://rdf.ncbi.nlm.nih.gov/pubmed/

• CD00332
  http://metadb.riken.jp/db/BrainTx/TranscriptomeData/CD00332